Woodmont Investment Counsel LLC Has $352,000 Stock Position in Colgate-Palmolive (NYSE:CL)

Woodmont Investment Counsel LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.0% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 3,914 shares of the company’s stock after selling 250 shares during the quarter. Woodmont Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $352,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Vest Financial LLC grew its position in shares of Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after buying an additional 74,337 shares during the period. Central Bank & Trust Co. grew its position in shares of Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares during the period. Dynamic Advisor Solutions LLC grew its position in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares during the period. Sarasin & Partners LLP grew its position in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after buying an additional 49,980 shares during the period. Finally, Cornerstone Wealth Management LLC grew its position in shares of Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.6 %

NYSE:CL opened at $96.12 on Wednesday. The firm has a market capitalization of $78.86 billion, a price-to-earnings ratio of 30.42, a price-to-earnings-growth ratio of 3.57 and a beta of 0.39. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $99.08. The stock’s 50 day moving average price is $94.02 and its two-hundred day moving average price is $87.76. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.73 EPS. Equities research analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.08%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CL shares. Royal Bank of Canada lifted their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. BNP Paribas started coverage on Colgate-Palmolive in a report on Monday, June 24th. They set an “outperform” rating and a $109.00 price objective on the stock. Bank of America lifted their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, April 29th. Stifel Nicolaus lifted their price objective on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a report on Monday, April 29th. Finally, Morgan Stanley lifted their price objective on Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, May 28th. Three equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $93.83.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares in the company, valued at $1,309,691.44. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.